Analysis of 3 years follow-up outcomes of bariatric surgery in adolescents with obesity

doi:10.3877/cma.j.issn.2095-9605.2018.04.003

Abstract

Abstract:

Objective

This retrospective study aimed to assess the midterm clinical outcomes of adolescents with obesity undergoing bariatric surgery.

Methods

Between Nov. 2014 to Oct. 2015, 16 adolescents (aged 13-21 years) undergoing the surgery in Changchun Jiahe Surgical Hospital were recruited to the study. Changes in body weight, BMI, triglyceride, high-density lipoprotein and low-density lipoprotein were assessed through 3 years after surgery.

Results

From baseline to 3 years follow-up, the mean body weight, BMI, TG and LDL levels decreased by different degrees, while the mean HDL level increased. These change were statistically significant (P<0.05).

Conclusions

Bariatric surgery can bring about sustained and significant weight reduction, and improve dyslipidemia issue in adolescents. This operation should be considered when they reached Grade II obesity.

Key words: Bariatric surgery, Adolescent, Obesity

Lele Wang, Mingxing Ding, He Xin, Zhanfei Wang, Liying Wang. Analysis of 3 years follow-up outcomes of bariatric surgery in adolescents with obesity[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2018, 04(04): 202-206.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2018.04.003

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2018/V04/I04/202

Figures/Tables 6

References 13

[1]	陈贻珊，张一民，孔振兴，等. 我国儿童青少年超重、肥胖流行现状调查[J]. 中华疾病控制杂志, 2017, 21(9): 866-869.
[2]	Skinner AC, Perrin EM, Moss LA, et al. Cardiometabolic risks and severity of obesity in children and young adults[J]. The New England Journal of Medicine, 2015, 373(14): 1307-1317.
[3]	Shah AS, D’Alessio D, Ford-Adams ME, et al. Bariatric surgery: a potential treatment for type 2 diabetes in youth. Diabetes Care[J]. 2016, 39(6): 934-940
[4]	Johnston CA, Tyler C, Palcic JL, et al. Smaller weight changes in standardized body mass index in response to treatment as weight classification increases[J]. The Journal of Pediatrics, 2011, 158(4): 624-627.
[5]	Inge TH, Jenkins TM, Xanthakos SA, et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis[J]. The Lancet Diabetes & Endocrinology, 2017, 5(3): 165-173.
[6]	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会.中国肥胖和2型糖尿病外科治疗指南(2014)[J].中国实用外科杂志, 2014, 8(11): 1005-1010.
[7]	Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during1980–2013: a systematic analysis for the Global Burden of Disease Study2013[J]. Lancet, 2014, 384(9945): 766-781.
[8]	Kelly AS, Rudser KD, Nathan BM, et al. The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial[J]. JAMA Pediatrics, 2013, 167(4): 355-360.
[9]	Olbers T, Beamish AJ, Gronowitz E, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study[J]. The Lancet Diabetes & Endocrinology, 2017, 5(3): 174-183.
[10]	Inge TH, Siegel RM, Xanthakos SA. Weight loss maintenance: a hard nut to crack[J]. JAMA Pediatrics, 2014, 168(9): 796-797.
[11]	Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial[J]. Lancet, 2015, 386(9997): 964-973.
[12]	Michalsky M, Reichard K, Inge T, et al. ASMBS pediatric committee best practice guidelines[J]. Surgery for Obesity and Relatated Diseases, 2012, 8: 1-7.
[13]	Kim J, Eisenberg D, Azagury D, et al. American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefi t after metabolic and bariatric surgery[J]. Surgery for Obesity and Relatated Diseases, 2016, 12(3): 453-459.

Descriptive Statistics随访时间点	BMI	体重	% decline M0-M36
M0	41.42±5.56	122.5±20.72	38.22%±9.22%
M1	36.21±5.59	107±19.01
M6	31.08±3.81	92±14.70
M12	27.73±2.9	81.9±10.36
M24	25.72±2.64	75.7±7.49
M36	25.71±3.14	75.7±8.67

Descriptive Statistics随访时间点	BMI	体重	% decline M0-M36
M0	41.42±5.56	122.5±20.72	38.22%±9.22%
M1	36.21±5.59	107±19.01
M6	31.08±3.81	92±14.70
M12	27.73±2.9	81.9±10.36
M24	25.72±2.64	75.7±7.49
M36	25.71±3.14	75.7±8.67

Descriptive Statistics N=16	TG		LDL		HDL
Descriptive Statistics N=16	Mean±Std	% decline	Mean±Std	% decline	Mean±Std	% decline
M0	1.70±0.78	33.46%±24.69%	3.6±1.17	37.63%±20.40%	1.04±0.18	-27.25%±27.72%
M36	0.98±0.20	33.46%±24.69%	2.07±0.42	37.63%±20.40%	1.28±0.12	-27.25%±27.72%

Descriptive Statistics N=16	TG		LDL		HDL
Descriptive Statistics N=16	Mean±Std	% decline	Mean±Std	% decline	Mean±Std	% decline
M0	1.70±0.78	33.46%±24.69%	3.6±1.17	37.63%±20.40%	1.04±0.18	-27.25%±27.72%
M36	0.98±0.20	33.46%±24.69%	2.07±0.42	37.63%±20.40%	1.28±0.12	-27.25%±27.72%

Paired Samples T Test	?	t	df	Sig. (2-tailed)
Pair 1	W0–W36	10.081	15	0.000
Pair 2	BMI0–BMI36	11.459	15	0.000
Pair 3	TG0–TG36	4.16	15	0.001
Pair 4	LDL0–LDL36	5.238	15	0.000
Pair 5	HDL0–HDL36	-4.028	15	0.001

Please choose a citation manager

Content to export